Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Por um escritor misterioso
Descrição
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Clot Chronicles: Thrombosis in Hospitalized Pediatric Patients with COVID-19 and MIS-C
Multisystem inflammatory syndrome in children: another COVID-19 sequel, Cardiology in the Young
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3 - Henderson - 2022 - Arthritis & Rheumatology - Wiley Online Library
Systematic review on the clinical presentation and management of the COVID- 19 associated multisystem inflammatory syndrome in children (MIS-C)
IJMS, Free Full-Text
Multisystem inflammatory syndrome in children: another COVID-19 sequel, Cardiology in the Young
Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID -19 — COVID-NET, 14 States, March 2020–February 2022
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
PDF) How we approach thrombosis risk in children with COVID‐19 infection and MIS‐C
IJMS, Free Full-Text
Post-SARS-CoV-2 Multisystemic Syndrome in the Paediatric Population of Pakistan: A Case Report - European Medical Journal
Elsevier – Clinical Overviews │ Multisystem inflammatory syndrome in children (MIS-C)
de
por adulto (o preço varia de acordo com o tamanho do grupo)
